skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Abbott Laboratories (ABT) sold off ~10–12% this morning after its earnings report and updated guidance. Is this business still worth holding despite the disappointing performance? What are your thoughts on its prospects? If you think ABT remains a good company based on the latest results, can you provide key valuation and profitability metrics such as forward P/E, PEG, ROE, and debt levels? Thanks.
Read Answer Asked by Adam on January 28, 2026
Q: Hello,
What do you think of IONQ's purchase of Skywater for $1.8 Billion. Also, would you consider IONQ as the go to name for quantum computing .. much appreciate it.
Read Answer Asked by umedali on January 27, 2026
Q: Hello 5i
How would you rank the following "memory" companies for growth over the next 3'ish years? Which would be your two favorites?
Thank you
Dave
Read Answer Asked by Dave on January 27, 2026
Q: Could I please have you rank the above stocks in terms of must have in a portfolio constructed today for the long term.
Read Answer Asked by Kyle on January 27, 2026
Q: Dear Peter et al:
Eric Nuttall on BNN Bloomberg today Wednesday Jan 21st chose US Natural Gas producers...all the three of his top picks!
With this mind I looked for an ETF that focuses on US Nat.Gas producers. LNGX came up. No questions on this ETF and the symbol isn't in your database. Too small and too new perhaps?

What's your take on this idea of US Nat.Gas being better than Canadian gas companies. Also your opinion on LNGX. Do you have any other suggestion for this play?
If I were to buy about 5 companies in Nat.Gas domain in the US, will I be able to match the returns of this ETF?

Many thanks.
Read Answer Asked by Savalai on January 27, 2026
Q: UNH appears to be in something of a no-man’s-land for the next year or two. An RBC DS report on January 21 says “intermediate-term recovery seems already priced in ” which suggests limited near-term upside. Disagree? I don't mean to prejudice your answer, but FYI CFRA also seems unimpressed with UNH’s prospects.
I’d appreciate your view on:
• Do you agree that UNH offers limited upside over the next 12–24 months, or do you see catalysts the market is missing?
• Have large loss which is not usable for tax. Would that factor into your hold vs. exit decision?
• If you believe UNH is still worth holding, please outline your rationale.

What do you show for current , updated forward P/E, PEG, and debt levels?
• More broadly, do you think the current U.S. administration and regulatory stance will constrain UNH’s ability to grow, and is there any risk that the core business model is now structurally impaired?
Many thanks! :ao:
Read Answer Asked by Adam on January 27, 2026
Q: Fiserve: nothing turns up for this company when I search on your market data page. Please see if the info is actually available.

And more for you...what is your opinion on FISV? It seems to be about 25% of its share price a year ago. Recent news stories show some promise. It reports in the next few weeks. What is expected? Would you jump in before it reports? Do you see a good chance for the share price to have a strong bounce? Or will it continue to flounder due to its past problems?

Many thanks for your excellent service
Read Answer Asked by Leonard on January 27, 2026
Q: Cls and sndk both exploded higher after being allowed to fly on their own.Cls fromOnex and Sndk from Wdc.Do you see any similar situations that companies may benefit from this opportunity?Thx
Read Answer Asked by blake on January 26, 2026
Q: I have just started an RESP for my grandson and will be contributing the max $2500 per year. What would you recommend as my first stock purchases.
Thank you
Read Answer Asked by Marty on January 26, 2026